Catalyst Wire Dossier Catalyst Wire Dossier

mRNA COVID-19 variant-containing vaccine formulations

· ModernaTX, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for mRNA COVID-19 variant-containing vaccine formulations, covering 2026-03-27 to 2026-03-27. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations [Phase 4]

See pricing